AU2020904531A0 - Treatment for tardbp associated disease - Google Patents

Treatment for tardbp associated disease

Info

Publication number
AU2020904531A0
AU2020904531A0 AU2020904531A AU2020904531A AU2020904531A0 AU 2020904531 A0 AU2020904531 A0 AU 2020904531A0 AU 2020904531 A AU2020904531 A AU 2020904531A AU 2020904531 A AU2020904531 A AU 2020904531A AU 2020904531 A0 AU2020904531 A0 AU 2020904531A0
Authority
AU
Australia
Prior art keywords
tardbp
treatment
associated disease
disease
tardbp associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020904531A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Perron Institute for Neurological and Translational Science Ltd
Original Assignee
Perron Institute for Neurological and Translational Science Ltd
Filing date
Publication date
Application filed by Perron Institute for Neurological and Translational Science Ltd filed Critical Perron Institute for Neurological and Translational Science Ltd
Publication of AU2020904531A0 publication Critical patent/AU2020904531A0/en
Priority to AU2021394117A priority Critical patent/AU2021394117A1/en
Priority to CN202180093026.3A priority patent/CN117279667A/en
Priority to EP21901697.9A priority patent/EP4255504A1/en
Priority to CA3201028A priority patent/CA3201028A1/en
Priority to KR1020237022338A priority patent/KR20230120127A/en
Priority to PCT/AU2021/051318 priority patent/WO2022120410A1/en
Priority to JP2023557464A priority patent/JP2023552493A/en
Abandoned legal-status Critical Current

Links

AU2020904531A 2020-12-07 2020-12-07 Treatment for tardbp associated disease Abandoned AU2020904531A0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AU2021394117A AU2021394117A1 (en) 2020-12-07 2021-11-08 Compositions and methods for treating tardbp associated diseases
CN202180093026.3A CN117279667A (en) 2020-12-07 2021-11-08 Compositions and methods for treating TARDBP-related diseases
EP21901697.9A EP4255504A1 (en) 2020-12-07 2021-11-08 Compositions and methods for treating tardbp associated diseases
CA3201028A CA3201028A1 (en) 2020-12-07 2021-11-08 Compositions and methods for treating tardbp associated diseases
KR1020237022338A KR20230120127A (en) 2020-12-07 2021-11-08 Compositions and methods for treating TARDBP-related diseases
PCT/AU2021/051318 WO2022120410A1 (en) 2020-12-07 2021-11-08 Compositions and methods for treating tardbp associated diseases
JP2023557464A JP2023552493A (en) 2020-12-07 2021-11-08 Compositions and methods for treating TARDBP-related diseases

Publications (1)

Publication Number Publication Date
AU2020904531A0 true AU2020904531A0 (en) 2021-01-07

Family

ID=

Similar Documents

Publication Publication Date Title
EP3954395A4 (en) Pharmaceutical composition for muscle disease treatment
EP3890725A4 (en) Compositions for treating dermatological diseases
EP3922264A4 (en) Pharmaceutical composition for preventing, ameliorating or treating skin disease
EP4000609A4 (en) Pharmaceutical composition for preventing or treating bone diseases
EP3852753A4 (en) Treatment for non-alcoholic fatty liver disease
EP3781695A4 (en) Mitochondrial rna import for treating mitochondrial disease
EP3969012A4 (en) Methods concerning ongoing treatment for cancer
EP3927375A4 (en) Compositions for disease treatment
EP4051379A4 (en) Therapeutic approach for treating inflammatory bowel disease
EP4101456A4 (en) Graphene-based composition for treating kidney disease
EP4017490A4 (en) Compounds and methods for treating oxalate-related diseases
EP3862012A4 (en) Therapeutic agent for neurodegenerative disease
EP3744347A4 (en) Composition for skin diseases treatment use
AU2022296903A1 (en) Treatment for autoimmune diseases
AU2020904531A0 (en) Treatment for tardbp associated disease
EP3963077A4 (en) Treatment for sod1 associated disease
EP4096783A4 (en) Compositions for hemorrhoid treatment
EP4058063A4 (en) Methods for treating diseases
EP4069251A4 (en) Salts and polymorphs of cethromycin for the treatment of disease salts and polymorphs of cethromycin
EP3733102A4 (en) Medical treatment tool
EP3925623A4 (en) Medicinal composition for preventing or treating bone diseases
EP3752614A4 (en) Oligonucleotide therapy for wilson disease
EP4098263A4 (en) Treatment for chondrodystrophia
AU2021901964A0 (en) New treatment for neurodegenerative diseases
AU2020902218A0 (en) New treatment for neurodegenerative diseases